Your browser is no longer supported. Please, upgrade your browser.
PerkinElmer, Inc.
IndexS&P 500 P/E17.20 EPS (ttm)9.55 Insider Own0.30% Shs Outstand112.03M Perf Week6.65%
Market Cap17.94B Forward P/E26.85 EPS next Y6.12 Insider Trans-5.42% Shs Float111.75M Perf Month6.27%
Income1.07B PEG0.45 EPS next Q2.41 Inst Own95.90% Short Float3.55% Perf Quarter21.76%
Sales4.44B P/S4.04 EPS this Y212.40% Inst Trans-0.35% Short Ratio5.13 Perf Half Y8.18%
Book/sh35.73 P/B4.60 EPS next Y-34.07% ROA14.20% Target Price161.21 Perf Year46.69%
Cash/sh9.05 P/C18.16 EPS next 5Y37.90% ROE30.80% 52W Range109.54 - 162.70 Perf YTD14.52%
Dividend0.28 P/FCF14.91 EPS past 5Y31.30% ROI14.00% 52W High1.01% Beta1.10
Dividend %0.17% Quick Ratio1.40 Sales past 5Y12.40% Gross Margin58.30% 52W Low50.03% ATR3.12
Employees14000 Current Ratio1.80 Sales Q/Q100.40% Oper. Margin31.60% RSI (14)77.85 Volatility2.04% 1.97%
OptionableYes Debt/Eq0.64 EPS Q/Q1026.70% Profit Margin24.20% Rel Volume1.12 Prev Close160.06
ShortableYes LT Debt/Eq0.55 EarningsJul 28 AMC Payout2.90% Avg Volume774.00K Price164.34
Recom2.10 SMA206.29% SMA5010.57% SMA20018.38% Volume864,737 Change2.67%
Jun-16-21Upgrade Wolfe Research Peer Perform → Outperform
Jan-07-21Upgrade Wells Fargo Equal Weight → Overweight $175
Dec-02-20Initiated Goldman Buy $160
Nov-10-20Initiated KeyBanc Capital Markets Sector Weight $150
Nov-09-20Reiterated Needham Buy $139 → $193
Sep-11-20Upgrade Needham Hold → Buy $139
Jul-29-20Upgrade CFRA Hold → Buy
Jan-08-20Initiated Wells Fargo Equal Weight $105
Jan-07-20Initiated Citigroup Neutral $100
Jan-02-20Upgrade Evercore ISI In-line → Outperform
Nov-15-19Initiated Stifel Buy
Oct-31-19Downgrade Piper Jaffray Overweight → Neutral $104 → $89
Sep-26-19Upgrade BofA/Merrill Neutral → Buy $105
May-30-19Initiated Wolfe Research Peer Perform
Apr-09-19Upgrade Goldman Neutral → Buy $115
Jan-03-19Initiated Needham Hold
Nov-02-18Downgrade Janney Buy → Neutral
Oct-09-18Initiated UBS Neutral
Sep-10-18Reiterated Deutsche Bank Hold $88 → $93
Dec-19-17Upgrade BofA/Merrill Underperform → Neutral
Jul-23-21 04:15PM  
Jul-22-21 09:43AM  
Jul-21-21 03:02PM  
Jul-19-21 01:19PM  
Jul-13-21 05:59AM  
Jul-08-21 08:30AM  
Jul-06-21 12:24PM  
Jun-28-21 08:50AM  
Jun-24-21 06:00AM  
Jun-23-21 09:40AM  
Jun-22-21 08:30AM  
Jun-16-21 02:27PM  
Jun-11-21 03:48AM  
Jun-07-21 08:08AM  
Jun-03-21 11:31AM  
Jun-02-21 04:21PM  
Jun-01-21 07:38AM  
May-27-21 10:30AM  
May-26-21 08:05AM  
May-25-21 06:08AM  
May-24-21 09:36AM  
May-19-21 08:22AM  
May-18-21 09:15AM  
May-17-21 08:30AM  
May-14-21 10:10AM  
May-13-21 08:45AM  
May-12-21 04:05PM  
May-11-21 09:15AM  
May-07-21 08:53AM  
May-06-21 03:19AM  
May-05-21 08:26AM  
May-04-21 05:00PM  
Apr-29-21 04:15PM  
Apr-27-21 09:15AM  
Apr-26-21 08:28AM  
Apr-23-21 12:10PM  
Apr-21-21 08:00AM  
Apr-19-21 01:50PM  
Apr-14-21 04:25PM  
Apr-13-21 04:15PM  
Apr-07-21 08:25AM  
Mar-30-21 12:19PM  
Mar-29-21 11:33AM  
Mar-26-21 08:57AM  
Mar-11-21 07:40AM  
Mar-09-21 08:00AM  
Mar-08-21 11:56AM  
Mar-04-21 07:24PM  
Feb-26-21 08:00AM  
Feb-23-21 08:00AM  
Feb-22-21 08:30AM  
Feb-16-21 08:00AM  
Feb-09-21 03:29PM  
Feb-05-21 11:09AM  
Feb-04-21 12:25PM  
Feb-03-21 04:32PM  
Feb-02-21 05:55PM  
Feb-01-21 10:05AM  
Jan-29-21 05:47AM  
Jan-28-21 04:15PM  
Jan-27-21 10:13AM  
Jan-26-21 12:31PM  
Jan-22-21 09:28AM  
Jan-21-21 12:45PM  
PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. The company operates in two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detection and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as laboratory services. It also provides analytical technologies, solutions, and services for the environmental, food, and industrial markets that enable its customers to understand the characterization and health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology and drug discovery. The company serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. PerkinElmer, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Gregoire SylvieDirectorJul 06Option Exercise46.275,000231,35022,390Jul 07 04:05 PM
Gregoire SylvieDirectorJul 06Sale155.575,000777,85017,390Jul 07 04:05 PM
Okun AndrewPlease See RemarksJun 10Sale145.712,370345,3338,252Jun 11 04:05 PM
Gregoire SylvieDirectorMay 13Option Exercise46.275,000231,35022,390May 14 04:05 PM
Gregoire SylvieDirectorMay 13Sale140.005,000700,00017,390May 14 04:05 PM
MICHAS ALEXIS PDirectorMay 11Sale140.234,750666,09266,631May 12 04:05 PM
MICHAS ALEXIS PDirectorApr 23Option Exercise42.094,750199,90469,637Apr 26 04:10 PM
Tereau Daniel RPlease See RemarksFeb 01Option Exercise81.292,047166,40111,118Feb 02 05:56 PM
Tereau Daniel RPlease See RemarksFeb 01Sale147.072,047301,0529,071Feb 02 05:56 PM
Goldberg Joel SPlease See RemarksJan 06Option Exercise46.2625,1491,163,26796,924Jan 07 04:33 PM
Goldberg Joel SPlease See RemarksJan 06Sale155.5225,1493,911,18271,775Jan 07 04:33 PM
Goldberg Joel SPlease See RemarksJan 05Option Exercise46.261,15853,56373,293Jan 07 04:33 PM
Singh Prahlad R.Please See RemarksJan 05Option Exercise46.2610,636491,96850,537Jan 07 04:59 PM
Singh Prahlad R.Please See RemarksJan 05Sale150.0010,6361,595,40039,901Jan 07 04:59 PM
Goldberg Joel SPlease See RemarksJan 05Sale152.511,518231,51171,775Jan 07 04:33 PM
Tereau Daniel RPlease See RemarksDec 14Option Exercise81.294,094332,80111,521Dec 15 04:10 PM
Tereau Daniel RPlease See RemarksDec 14Sale146.684,094600,5087,427Dec 15 04:10 PM
Okun AndrewPlease See RemarksNov 06Option Exercise81.296,107496,43816,417Nov 09 04:05 PM
Okun AndrewPlease See RemarksNov 06Sale140.146,107855,83510,310Nov 09 04:05 PM
Mock James MPlease See RemarksOct 02Sale124.415,623699,58427,218Oct 05 04:05 PM
Goldberg Joel SPlease See RemarksJul 31Option Exercise43.0123,3871,005,87595,179Aug 03 04:05 PM
Goldberg Joel SPlease See RemarksJul 31Sale117.8423,3872,755,82571,792Aug 03 04:05 PM
Okun AndrewPlease See RemarksJul 29Option Exercise52.654,699247,40217,009Jul 30 06:42 PM
Okun AndrewPlease See RemarksJul 29Sale120.006,699803,88010,310Jul 30 06:42 PM